(2-Chloro-pyrimidin-4-yl)-ethyl-amine, 95.0%, 1g

methyl 1H-1,2,3-triazole-5-carboxylate, 97%, 10g

2-((tert-Butoxycarbonyl)amino)isonicotinic acid, 95.0%, 5g

Vinylphenyldimethylsilane, 95%, 100g

N-(4-methoxybenzyl)-1-adamantanamine hydrobromide, 95.0%, 1g

ETHYL 5-AMINOBENZOFURAN-2-CARBOXYLATE HCL, 97.0%, 5g

Methyl 5-chloro-2-(methylthio)pyrimidine-4-carboxylate, 95.0%, 5g

Nicotinic Acid [Matrix for MALDI-TOF/MS]>99.5%(HPLC)(T)5g

tert-Butyl 3-hydroxy-3-(hydroxymethyl)azetidine-1-carboxylate, 98%, 5g

2-(2,6-Dimethoxybenzoyl)-4-methylpyridine, 97.0%, 1g

HBPYU, 99.0%, 1g

(S)-(5,5-DIMETHYLTETRAHYDROFURAN-2-YL)METHANOL, 95.0%, 1g

(3-formyl-5-methoxy-1H-indol-1-yl)acetic acid, 250mg